News

<>

February 29, 2016

Pink Sheet

Roche Reviewing Next Steps For Lebrikizumab After Mixed Phase III Data

By Jessica Merrill

One of two identical Phase III trials testing the IL-13 blocker in severe asthma patients met its primary endpoint, while the other failed.

read full article >